Is It Too Late To Consider Teva (TEVA) After Its 118% One Year Share Price Surge? [Yahoo! Finance]
Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
Last teva pharmaceutical industries limited american depositary shares earnings: 2/13 04:01 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.tevapharm.com
Company Research
Source: Yahoo! Finance
If you are wondering whether Teva Pharmaceutical Industries at around US$31.22 still offers value or is looking stretched, you are not alone. The stock has seen a mixed but eye catching run, with a 1.2% decline over the last 7 days, an 8.5% gain over 30 days, 0.9% year to date, and 118.5% over the past year. The 3 year and 5 year returns sit at 280.3% and 208.5% respectively. Recent headlines have focused on Teva Pharmaceutical Industries as investors reassess large past returns and the risks tied to the pharmaceutical sector. This context matters for you because sentiment around regulation, competition, and balance sheet strength can quickly influence how the market prices the stock. Simply Wall St currently gives Teva Pharmaceutical Industries a value score of 3 out of 6 . The rest of this article will walk through traditional valuation methods before finishing with a more complete way to think about what that score really means for you as an investor. Teva Pharmaceutical I
Show less
Read more
Impact Snapshot
Event Time:
TEVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TEVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TEVA alerts
High impacting Teva Pharmaceutical Industries Limited American Depositary Shares news events
Weekly update
A roundup of the hottest topics
TEVA
News
- Teva Pharmaceutical Industries (TEVA) had its "sell (d-)" rating reaffirmed by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Teva Pharmaceutical Industries Limited (TEVA): David Einhorn Trims Holding [Yahoo! Finance]Yahoo! Finance
- 3 Catalysts That Could Send Teva Stock to $40 and Beyond [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- How Teva Pharmaceutical Industries (TEVA) Story Is Shifting With Duvakitug R&D And Biosimilars [Yahoo! Finance]Yahoo! Finance
- Teva Launches Home Groundâ„¢ Schizophrenia Community, a New Online Resource Hub for People Living with Schizophrenia and Their Care PartnersGlobeNewswire
TEVA
Earnings
- 1/28/26 - Beat
TEVA
Sec Filings
- 3/31/26 - Form DEFA14A
- 3/31/26 - Form ARS
- 3/31/26 - Form DEF
- TEVA's page on the SEC website